VIDEO BRIEFING: Reduce your credit card swipe fees
Missed our briefing a couple of weeks ago about APC’s new group purchasing agreement with WorldPay?
Missed our briefing a couple of weeks ago about APC’s new group purchasing agreement with WorldPay?
Plus: Letendre honored and APC represents at recent convention
It’s called geofencing — the ability to target digital messaging to individuals who meet a defined demographic criteria within a defined geographic area.
It’s the 4th quarter. Can we come from behind? It’s the start of the fourth quarter and we’re behind — and I’m not talking about a football game.
In light of recent developments, we’ve updated our official statement on shortage drug compounding and semaglutide, as well as our Prescriber Brief on peptide compounding.
Last week, a Florida District Court judge dismissed Novo Nordisk’s lawsuit against Brooksville Pharmacy, one of the four APC members the drugmaker sued back in June over semaglutide compounding in shortage.
APC has leveraged the strength of our large number of Pharmacy-Facility Members to strike a deal with Capital Drug on finished-form drugs.
FDA this week issued a statement warning of potential risks associated with compounded ketamine, including oral formulations, for treatment of psychiatric disorders.
The providers you work with may be smart cookies, but they don’t always know compounding. Providers need to know about those issues, and it’s up to you to keep them informed.
Voting is now open for seats on the 2024 APC Board of Directors.
CompPAC is the way APC supports members of Congress who think like you do about pharmacy compounding. And where does CompPAC get its funding? From compounders like you.
APC staff has prepared a comparison document illuminating the differences between the new USP Chapter <797> on sterile compounding that takes effect November 1 and proposed regulation from the California Board of Pharmacy.
Five U.S. Senators have written to the FDA urging that the agency assure continued patient access to compounded hormones for patients.
Last Friday, the FDA announced that it has updated the list of bulk drug substances nominated for use under section 503A.
Did they or didn’t they? Did USP take seriously input from APC (as well as that of APhA, NCPA, and numerous other pharmacy stakeholder groups)?
Jack Korbutov says the system is already paying dividends.
The Outsourcing Facilities Association announced this week that it reached a settlement agreement with the FDA.
22 members of Congress urged FDA to “craft patient-centered policies that preserve treatment options” related to compounded hormones.
Mention this letter to your pharmacy board members and executive director.
It debuted last week.
The Kentucky Society of Association Executives has directed those who want to help to this list of local charity organizations.
How do you think currently proposed revisions to USP Chapters 795 and 797 will affect your patients and pharmacy practice? We need to hear from you, and soon!
One small thing you can do to help promote APC’s campaign to save compounded hormones.
350 pharmacies donated to APC’s effort to save compounded hormones!
The dollars are not yet rolling in for 2022. And it has us worried.
APC’s comment letter was submitted in response to FDA’s proposed Revised Draft Guidance for Industry.
Doing things right in your compounding practice is your best form of protection. That’s what EduCon 2022 Virtual is all about.
ACPE is looking for comments.
APC member Peter Koshland is the featured guest on this great episode of the Pharmacy Podcast. Download ‘The Profound Impact of High Quality Compounded Medications’ and listen. … (Read the rest)
December 31 is coming fast, but you still have time to realize the tax benefits of a contribution to the Pharmacy Compounding Foundation.